Literature DB >> 25144502

Cerebral Glucose Metabolism and Sedation in Brain-injured Patients: A Microdialysis Study.

Daniel N Hertle1, Edgar Santos, Anna M Hagenston, Christine Jungk, Daniel Haux, Andreas W Unterberg, Oliver W Sakowitz.   

Abstract

BACKGROUND: Disturbed brain metabolism is a signature of primary damage and/or precipitates secondary injury processes after severe brain injury. Sedatives and analgesics target electrophysiological functioning and are as such well-known modulators of brain energy metabolism. Still unclear, however, is how sedatives impact glucose metabolism and whether they differentially influence brain metabolism in normally active, healthy brain and critically impaired, injured brain. We therefore examined and compared the effects of anesthetic drugs under both critical (<1 mmol/L) and noncritical (>1 mmol/L) extracellular brain glucose levels.
METHODS: We performed an explorative, retrospective analysis of anesthetic drug administration and brain glucose concentrations, obtained by bedside microdialysis, in 19 brain-injured patients. RESULT: Our investigations revealed an inverse linear correlation between brain glucose and both the concentration of extracellular glutamate (Pearson r=-0.58, P=0.01) and the lactate/glucose ratio (Pearson r=-0.55, P=0.01). For noncritical brain glucose levels, we observed a positive linear correlation between midazolam dose and brain glucose (P<0.05). For critical brain glucose levels, extracellular brain glucose was unaffected by any type of sedative.
CONCLUSIONS: These findings suggest that the use of anesthetic drugs may be of limited value in attempts to influence brain glucose metabolism in injured brain tissue.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25144502     DOI: 10.1097/ANA.0000000000000107

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  2 in total

Review 1.  What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment.

Authors:  Cesar Reis; Yuechun Wang; Onat Akyol; Wing Mann Ho; Richard Applegate Ii; Gary Stier; Robert Martin; John H Zhang
Journal:  Int J Mol Sci       Date:  2015-05-26       Impact factor: 5.923

2.  Cerebrospinal fluid metabolic profiling reveals divergent modulation of pentose phosphate pathway by midazolam, propofol and dexmedetomidine in patients with subarachnoid hemorrhage: a cohort study.

Authors:  Yi-Chen Li; Rong Wang; Ji-Ye A; Run-Bin Sun; Shi-Jie Na; Tao Liu; Xuan-Sheng Ding; Wei-Hong Ge
Journal:  BMC Anesthesiol       Date:  2022-01-27       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.